Torsten Dahlén
Karolinska Institutet
H-index: 10
Europe-Sweden
Top articles of Torsten Dahlén
Using routine health-care data to search for unknown transfusion-transmitted disease: a nationwide, agnostic retrospective cohort study
The Lancet Digital Health
2024/2/1
Torsten Dahlén
H-Index: 5
Gustaf Edgren
H-Index: 30
Intracerebral hemorrhage among blood donors and their transfusion recipients
JAMA
2023/9/12
The impact of Covid-19 in patients with chronic myeloid leukemia—a nationwide population-based study
Leukemia
2023/5
Torsten Dahlén
H-Index: 5
Anders Själander
H-Index: 22
Susannah Leach
H-Index: 5
Huiqi Li
H-Index: 12
Fredrik Nyberg
H-Index: 35
A population‐based, retrospective cohort study of the association between ABO blood group and risk of COVID‐19
Journal of Internal Medicine
2023/3
Agnostic Studies in Epidemiology
2023
Torsten Dahlén
H-Index: 5
MSR132 Integrating Relative Survival Framework for Survival Extrapolation in Multi-State Models—An Application to Predicting Quality-Adjusted Life Years for Chronic Myeloid …
Value in Health
2022/12/1
Effectiveness of Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) after Two or More Prior Tyrosine Kinase Inhibitors
Blood
2022/11/15
Torsten Dahlén
H-Index: 5
Neutrophil‐to‐lymphocyte ratios in patients undergoing aortic valve replacement: the PARTNER trials and registries
Journal of the American Heart Association
2022/6/7
Adverse outcomes in chronic myeloid leukemia patients treated with tyrosine kinase inhibitors: follow‐up of patients diagnosed 2002–2017 in a complete coverage and nationwide …
American Journal of Hematology
2022/4
The frequency of misattributed paternity in Sweden is low and decreasing: A nationwide cohort study
Journal of internal medicine
2022/1
Torsten Dahlén
H-Index: 5
Gustaf Edgren
H-Index: 30
Overall survival and adverse events in 378 ibrutinib-treated patients with chronic lymphocytic leukemia-a Swedish register-based nationwide study
Blood
2021/11/23
Treatment Patterns in Patients with Chronic Myeloid Leukemia in Chronic Phase in the Third Line of TKI Therapy and Beyond Based on Real-World Evidence
Blood
2021/11/23
Successful tyrosine kinase inhibitor discontinuation outside clinical trials—data from the population‐based Swedish chronic myeloid leukaemia registry
British journal of haematology
2021/6
Fredrik Sandin
H-Index: 12
Torsten Dahlén
H-Index: 5
Anders Själander
H-Index: 22
Johan Richter
H-Index: 29
Costs associated with transfusion therapy in patients with myelodysplastic syndromes in Sweden: a nationwide retrospective cohort study
Vox sanguinis
2021/5
An agnostic study of associations between ABO and RhD blood group and phenome-wide disease risk
Elife
2021/4/27
TCT CONNECT-82 Prognostic Value of Serial Neutrophil-to-Lymphocyte Ratio in Patients Undergoing Transcatheter or Surgical Aortic Valve Replacement: The PARTNER I-II Trials and …
Journal of the American College of Cardiology
2020/10/27
Risk of hematological malignancy in blood donors: a nationwide cohort study
Transfusion
2020/8/20
Measurable health effects associated with the daylight saving time shift
PLoS computational biology
2020/6/8
Co-Authors
